The current BLUE market cap is 95.5M. The company's latest EPS is USD -1.0928 and P/E is -0.45.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.38M | 6.89M | 12.39M | 7.83M | 18.57M |
Operating Income | -84.49M | -85.3M | -84.73M | -82.67M | -78.69M |
Net Income | 21.24M | -72.91M | -71.73M | -88.51M | -69.8M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 44.67M | 257.2M | 31.31M | 3.6M | 29.5M |
Operating Income | -814.83M | -623.05M | -563.26M | -389.09M | -337.19M |
Net Income | -789.61M | -618.7M | -819.38M | -266.58M | -211.91M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 692.74M | 663.39M | 613.61M | 619.16M | 631.48M |
Total Liabilities | 338M | 374.37M | 391.07M | 424.62M | 500.44M |
Total Equity | 354.74M | 289.02M | 222.54M | 194.54M | 131.05M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.73B | 1.78B | 593.8M | 554.9M | 619.16M |
Total Liabilities | 442.43M | 426.2M | 219.52M | 358.56M | 424.62M |
Total Equity | 1.28B | 1.36B | 374.28M | 196.34M | 194.54M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -86.64M | -159.36M | -221.21M | -235.05M | -74.68M |
Investing | 82.14M | 89.08M | 151.16M | 154.95M | -655k |
Financing | 130.46M | 130.01M | 129.97M | 196.25M | 64.65M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -564.38M | -470.35M | -635.64M | -352.95M | -235.05M |
Investing | 507.81M | -84.35M | 562.56M | 250.45M | 154.95M |
Financing | 21.19M | 546.72M | -93.95M | 54.25M | 196.25M |
Market Cap | 95.5M |
Price to Earnings Ratio | -0.45 |
Price to Sales Ratio | 3.22 |
Price to Cash Ratio | 0.43 |
Price to Book Ratio | 0.49 |
Dividend Yield | - |
Shares Outstanding | 193.91M |
Average Volume (1 week) | 7.95M |
Average Volume (1 Month) | 7.76M |
52 Week Change | -83.08% |
52 Week High | 5.53 |
52 Week Low | 0.4529 |
Spread (Intraday) | 0.01 (1.14%) |
Company Name | bluebird bio Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.bluebirdbio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.